2. The report “Molecular Diagnostics Market by Application (Infectious Disease
(HIV, HPV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Microarray,
DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments,
Reagent, Software) - Forecast to 2020” provides a detailed overview of the major
drivers, restraints, threats, opportunities, current market trends, and strategies
impacting the market along with estimates and forecasts of revenue.
Browse 241 market data tables with 61 figures across 287 pages and in-depth
TOC on “Molecular Diagnostics Market by Application (Infectious Disease (HIV,
HPV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Microarray, DNA
Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent,
Software) - Forecast to 2020"
http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-
market-833.html
http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-
833.html
3. Early buyers will receive 10% customization on this report.
http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-
833.html
4. The molecular diagnostics market is poised to reach USD 9,333.8
Million by 2020 from USD 5,983.5 Million in 2015, at a CAGR of
9.3% from 2015 to 2020.
Factors such as high prevalence of infectious diseases and various
types of cancer; increasing awareness and acceptance of
personalized medicine and companion diagnostics; development
of biomarkers; and advancements in molecular techniques,
proteomics, and reformations in the reimbursement system are
driving the growth of the market.
http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-
833.html
5. The molecular diagnostics market is broadly segmented on the
basis of technologies, applications, products & services, and end
users. The major technologies studied in the report include PCR,
INAAT, microarrays, hybridization, DNA sequencing and next-
generation sequencing (NGS), and other technologies. Among
these technologies, PCR is expected to command the largest share
in 2015 while microarrays is expected to grow at the highest CAGR
during the forecast period.
http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-
833.html
6. The molecular diagnostics market, by application, is classified
into infectious diseases, oncology, genetics, blood screening,
microbiology, and others (cardiovascular diseases, neurological
diseases, DNA fingerprinting, tissue typing, and food pathogen
detection testing). The infectious diseases segment will account
for the largest share of the global molecular diagnostics market
in 2015, followed by the blood screening and oncology
segments.
http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-
833.html
7. On the basis of products and services, the molecular diagnostics
market is segmented into instruments, reagents, and services &
software. The reagents segment is expected to account for the
largest share and highest CAGR of the molecular diagnostics
market in 2015.
Based on end users, the market is subsegmented into hospital &
academic laboratories, reference laboratories, and others (blood
banks, local public health laboratories, home health agencies,
nursing homes, point-of-care settings, and self-testing).
http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-
833.html
8. As most diagnostic tests are carried out in-house, the hospital &
academic laboratories segment is expected to dominate the
market. On the other hand, newly launched, complex, and
highly specialized tests are mostly offered only at a few large
reference laboratories, owing to which the reference
laboratories segment is expected to witness the highest
growth rate during the forecast period.
http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-
833.html
9. Major players operating in the molecular diagnostics market are
Roche Diagnostics (U.S.), QIAGEN N.V. (Netherlands), Hologic
Inc. (U.S.), Grifols (Spain), Abbott Laboratories (U.S.), Siemens
Healthcare (Germany), Becton, Dickinson and Company
(U.S.), Beckman Coulter Inc. (U.S.), bioMérieux SA (France),
and Cepheid Inc. (U.S.).
http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-
833.html
10. Contact Us
Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com
http://www.linkedin.com/company/marketsandmarkets
http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-
833.html
11. About MarketsandMarkets
MarketsandMarkets is the world’s No. 2 firm in terms of annually published
premium market research reports. Serving 1700 global fortune enterprises with
more than 1200 premium studies in a year, M&M is catering to a multitude of
clients across 8 different industrial verticals. We specialize in consulting
assignments and business research across high growth markets, cutting edge
technologies and newer applications. Our 850 fulltime analyst and SMEs at
MarketsandMarkets are tracking global high growth markets following the
"Growth Engagement Model – GEM". The GEM aims at proactive collaboration
with the clients to identify new opportunities, identify most important
customers, write "Attack, avoid and defend" strategies, identify sources of
incremental revenues for both the company and its competitors.
http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-
833.html